NO871861D0 - Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer.

Info

Publication number
NO871861D0
NO871861D0 NO871861A NO871861A NO871861D0 NO 871861 D0 NO871861 D0 NO 871861D0 NO 871861 A NO871861 A NO 871861A NO 871861 A NO871861 A NO 871861A NO 871861 D0 NO871861 D0 NO 871861D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
dopamine beta
hydroxylase inhibitors
new dopamine
Prior art date
Application number
NO871861A
Other languages
English (en)
Other versions
NO871861L (no
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Jr Robert J Broersma
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO871861D0 publication Critical patent/NO871861D0/no
Publication of NO871861L publication Critical patent/NO871861L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Solid Wastes (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO871861A 1986-05-06 1987-05-05 Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer. NO871861L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86026386A 1986-05-06 1986-05-06

Publications (2)

Publication Number Publication Date
NO871861D0 true NO871861D0 (no) 1987-05-05
NO871861L NO871861L (no) 1987-11-09

Family

ID=25332828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871861A NO871861L (no) 1986-05-06 1987-05-05 Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer.

Country Status (17)

Country Link
EP (1) EP0244803B1 (no)
JP (1) JP2581556B2 (no)
KR (1) KR950013028B1 (no)
CN (1) CN87103323A (no)
AT (2) ATE113283T1 (no)
AU (1) AU596410B2 (no)
CA (1) CA1334199C (no)
DE (1) DE3750685T2 (no)
DK (1) DK229187A (no)
ES (1) ES2065881T3 (no)
FI (1) FI871981A (no)
HU (1) HU198479B (no)
IL (1) IL82401A0 (no)
NO (1) NO871861L (no)
NZ (1) NZ220184A (no)
PT (1) PT84823B (no)
ZA (1) ZA873176B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
EP0277384A3 (en) * 1986-12-24 1990-05-23 Janssen Pharmaceutica N.V. 1h-imidazole-5-carboxylic acid derivatives
EP0285356A3 (en) * 1987-03-30 1989-05-31 Smithkline Beecham Corporation Dopamine-beta-hydroxylase inhibitors
US4839375A (en) * 1987-07-28 1989-06-13 Merrell Dow Pharmaceuticals Inc. (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents
HU202516B (en) * 1987-10-02 1991-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing (2-thenyl)-thiourea derivatives and yield increasing agents comprising such compounds
CA2002246A1 (en) * 1988-12-01 1990-06-01 Lawrence I. Kruse Dopamine-.beta.-hydroxylase inhibitors
CA2002247A1 (en) * 1988-12-01 1990-06-01 Lawrence I. Kruse Dopamine-.beta.-hydroxylase inhibitors
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
DE19627310A1 (de) * 1996-06-27 1998-01-02 Schering Ag Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
WO2008021338A2 (en) 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
US7649007B2 (en) 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
US7652018B2 (en) 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
WO2009097416A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Imidazolylalkyl- pyridines as dbh inhibitors
CN103214421B (zh) * 2012-12-11 2016-03-02 上海博康精细化工有限公司 2-巯基-1-甲基咪唑的工业化生产方法
EP4285898A1 (en) 2021-01-26 2023-12-06 Jiangsu Yahong Meditech Co., Ltd. Pathway modulator, pharmaceutical composition having same, use thereof, and therapeutic method using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE312877C (no) *
NL6614808A (no) * 1965-10-21 1967-04-24
FR2073427A1 (en) * 1969-11-28 1971-10-01 Sogeras 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
GB2028317B (en) * 1978-08-15 1982-11-10 Pfizer Ltd 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
GR73560B (no) * 1979-02-24 1984-03-15 Pfizer
DE3128277A1 (de) * 1981-07-17 1983-02-03 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(5-(1-imidazolylmethyl)-thien-2-y1)-alkancarbonsaeuren und deren derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3228266A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Imidazolylalkylthiophene, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3300795A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Substituierte 4-imidazolyl-pyrazole, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
JPS6289956A (ja) * 1985-06-19 1987-04-24 Daicel Chem Ind Ltd 光発色画像組成物
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols

Also Published As

Publication number Publication date
KR950013028B1 (ko) 1995-10-24
DE3750685D1 (de) 1994-12-01
DE3750685T2 (de) 1995-03-02
JP2581556B2 (ja) 1997-02-12
DK229187A (da) 1987-11-07
NZ220184A (en) 1990-04-26
NO871861L (no) 1987-11-09
IL82401A0 (en) 1987-11-30
KR870011104A (ko) 1987-12-21
CA1334199C (en) 1995-01-31
CN87103323A (zh) 1988-02-03
ES2065881T3 (es) 1995-03-01
AT387967B (de) 1989-04-10
ZA873176B (en) 1987-10-28
EP0244803A3 (en) 1991-01-16
HU198479B (en) 1989-10-30
EP0244803A2 (en) 1987-11-11
FI871981A0 (fi) 1987-05-05
DK229187D0 (da) 1987-05-05
HUT44029A (en) 1988-01-28
JPH01100160A (ja) 1989-04-18
AU7246387A (en) 1987-11-12
AU596410B2 (en) 1990-05-03
ATA269087A (de) 1988-09-15
FI871981A (fi) 1987-11-07
PT84823A (en) 1987-06-01
PT84823B (pt) 1989-12-29
EP0244803B1 (en) 1994-10-26
ATE113283T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
NO871861D0 (no) Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer.
ES533338A0 (es) Derivados de la 2-pirimidinil-1-piperazina
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
FI905957A0 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
AU548628B2 (en) Novel guanidine derivatives
NO884367D0 (no) Fremgangsmaate for fremstilling av nye aminoalkylsubstituerte heterocykliske svovelforbindelser.
NO168580C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer
DK46884D0 (da) 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner,fremgangsmaade til deres fremstilling samt deres anvendelse